SKI Market

Indian Indices

Sensex

83,576.24 -604.72
( -0.72%)

Global Indices

Nasdaq

49,520.87 233.75
(0.47%)

Dow Jones

6,986.78 44.32
(0.64%)

Hang Seng

51,918.01 800.75
(1.57%)

Nikkei 225

10,123.15 78.46
(0.78%)

Forex

USD-INR

89.91 -0.02
(-0.02%)

EUR-INR

104.90 -0.20
(-0.19%)

GBP-INR

120.86 -0.43
(-0.35%)

JPY-INR

0.57 0.00
(-0.15%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Unjha Formulations Ltd

Industry : Pharmaceuticals - Indian - Formulations

BSE Code

ISIN Demat

Book Value()

531762

INE576D01015

9.7013726

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

N.A

10.47

10.74

EPS(TTM)

Face Value()

Div & Yield %

2.29

Back

Aerpace Industries reports standalone net loss of Rs 1.28 crore in the June 2025 quarter

Aug 15,2025

Net Loss of Aerpace Industries reported to Rs 1.28 crore in the quarter ended June 2025 as against net loss of Rs 0.45 crore during the previous quarter ended June 2024. Sales rose 30.77% to Rs 0.51 crore in the quarter ended June 2025 as against Rs 0.39 crore during the previous quarter ended June 2024.

Particulars	Quarter Ended
	Jun. 2025	Jun. 2024	% Var.
Sales	0.51	0.39	31
OPM %	-231.37	-125.64	-
PBDT	-0.84	-0.36	-133
PBT	-1.35	-0.44	-207
NP	-1.28	-0.45	-184

83,576.24 -604.72 ( -0.72%)

49,520.87 233.75 (0.47%)

6,986.78 44.32 (0.64%)

51,918.01 800.75 (1.57%)

10,123.15 78.46 (0.78%)

89.91 -0.02 (-0.02%)

104.90 -0.20 (-0.19%)

120.86 -0.43 (-0.35%)

0.57 0.00 (-0.15%)